CenturyLink Investment Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

CenturyLink Investment Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,660	Closed	-$303K	–	264
2016 Q1	$303K	Buy	5,660 +3,191	+129%	+$236K	0.11%	186
2015 Q4	$279K	Buy	2,469 +178	+8%	+$19.6K	0.1%	205
2015 Q3	$270K	Buy	+2,291	New	+$299K	0.09%	204

Other funds holding ANAC

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $417M AUM 49.77% 1-Year Est. Return

CenturyLink Investment Management's ANAC Position: Q2 2016 in Review

CenturyLink Investment Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 5,660 shares — an estimated $303K sold.

CenturyLink Investment Management first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $303K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

CenturyLink Investment Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
CenturyLink Investment Management sold 5,660 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $303K.
CenturyLink Investment Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
CenturyLink Investment Management's ANACOR PHARMACEUTICALS INC COM position peaked at $303K in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on CenturyLink Investment Management's 13F filing for Q2 2016, filed 7 Jul 2016.